This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Benitec Biopharma Limited, Biocross Institute of Molecular Medicine (Nantong) Co., Ltd., Biomics Biotechnologies, Co., Ltd.. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jiangshu, CN (2015 - 2016)
- Nantong, CN (2012 - 2017)
Company Filing History:
3 out of 8 
1 out of 1 
1 out of 7 Years Active: 2012-2017
Title: Innovations of YunCheng Sun in Hepatitis B Treatment
Introduction
YunCheng Sun is a notable inventor based in Nantong, China. He has made significant contributions to the field of medical science, particularly in the treatment of hepatitis B. With a total of 5 patents to his name, his work focuses on innovative RNA interference (RNAi) agents that target the Hepatitis B virus (HBV).
Latest Patents
One of YunCheng Sun's latest patents involves the development of RNA interference agents aimed at treating hepatitis B infection. This invention is directed to an RNAi agent and its use in inhibiting the expression of at least one HBV gene. The RNAi agents comprise effector sequences that are complementary to a predicted sequence transcribed from a target region. In some instances, these agents contain multiple effector sequences that may target the same region of an HBV gene or different regions of the same gene. This innovative approach offers a promising avenue for effective treatment of hepatitis B.
Career Highlights
Throughout his career, YunCheng Sun has worked with several prominent organizations. He has been associated with Benitec Biopharma Limited and the Biocross Institute of Molecular Medicine (Nantong) Co., Ltd. His work in these institutions has allowed him to further his research and development in the field of molecular medicine.
Collaborations
YunCheng Sun has collaborated with notable colleagues such as YiXiang Lu and York YuanYuan Zhu. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
YunCheng Sun's innovative work in the field of hepatitis B treatment through RNA interference agents showcases his dedication to advancing medical science. His contributions are significant in the ongoing fight against viral infections, and his patents reflect a commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile